胰岛β细胞Wtap缺失导致小鼠β细胞衰竭和糖尿病
本研究构建胰岛β细胞特异性Wtap敲除和β细胞特异性Mettl3过表达小鼠,发现Wtap敲除小鼠从8周龄起出现严重高血糖(>20 mmol/l)。机制上WTAP通过维持METTL3蛋白水平影响m6A修饰和β细胞功能基因表达,Mettl3过表达可部分逆转异常。
要点
- 胰岛β细胞特异性Wtap敲除小鼠从8周龄起出现严重高血糖(>20 mmol/l)。
- WTAP缺陷通过降低METTL3蛋白水平减少m6A修饰和β细胞功能基因表达。
- β细胞特异性Mettl3过表达可部分逆转Wtap敲除小鼠的异常。
核心结论
- WTAP通过依赖METTL3的m6A mRNA修饰维持β细胞功能,WTAP下调导致β细胞衰竭和糖尿病。
研究设计与样本
- 研究构建了胰岛β细胞特异性Wtap敲除小鼠和β细胞特异性Mettl3过表达小鼠。
- 检测了血糖、糖耐量、血清胰岛素、体内外葡萄糖刺激的胰岛素分泌、胰岛素水平、胰高血糖素水平和β细胞凋亡。
- 进行了RNA-seq和MeRIP-seq并分析数据。
主要发现
- WTAP在2型糖尿病胰岛β细胞中因脂毒性和慢性炎症而下调。
- Wtap-βKO小鼠从8周龄起出现严重高血糖(>20 mmol/l [360 mg/dl])。
- WTAP缺陷降低m6A mRNA修饰,并通过降低METTL3蛋白水平减少胰岛β细胞特异性转录因子和胰岛素分泌相关基因表达。
- β细胞特异性Mettl3过表达部分逆转了Wtap-βKO小鼠中观察到的异常。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: N6-methyladenosine (m6A) mRNA methylation and m6A-related proteins (methyltransferase-like 3 [METTL3], methyltransferase-like 14 [METTL14] and YTH domain containing 1 [YTHDC1]) have been shown to regulate islet beta cell function and the pathogenesis of diabetes. However, whether Wilms' tumour 1-associating protein (WTAP), a key regulator of the m6A RNA methyltransferase complex, regulates islet beta cell failure during pathogenesis of diabetes is largely unknown. The present study aimed to investigate the role of WTAP in the regulation of islet beta cell failure and diabetes. METHODS: Islet beta cell-specific Wtap-knockout and beta cell-specific Mettl3-overexpressing mice were generated for this study. Blood glucose, glucose tolerance, serum insulin, glucose-stimulated insulin secretion (both in vivo and in vitro), insulin levels, glucagon levels and beta cell apoptosis were examined. RNA-seq and MeRIP-seq were performed, and the data were well analysed. RESULTS: WTAP was downregulated in islet beta cells in type 2 diabetes, due to lipotoxicity and chronic inflammation, and islet beta cell-specific deletion of Wtap (Wtap-betaKO) induced beta cell failure and diabetes. Wtap-betaKO mice showed severe hyperglycaemia (above 20 mmol/l [360 mg/dl]) from 8 weeks of age onwards. Mechanistically, WTAP deficiency decreased m6A mRNA modification and reduced the expression of islet beta cell-specific transcription factors and insulin secretion-related genes by reducing METTL3 protein levels. Islet beta cell-specific overexpression of Mettl3 partially reversed the abnormalities observed in Wtap-betaKO mice. CONCLUSIONS/INTERPRETATION: WTAP plays a key role in maintaining beta cell function by regulating m6A mRNA modification depending on METTL3, and the downregulation of WTAP leads to beta cell failure and diabetes. DATA AVAILABILITY: The RNA-seq and MeRIP-seq datasets generated during the current study are available in the Gene Expression Omnibus database repository ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215156 ; https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215360 ).
引用
- Li X, Yang Y, Li Z, et al. Deficiency of WTAP in islet beta cells results in beta cell failure and diabetes in mice. Diabetologia. 2023. PMID: 36920524. doi:10.1007/s00125-023-05900-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。